This improves your reproductive success with the specific selection of embryos which are chromosomally normal. This procedure allows us to analyze all 24 chromosome types in order to discard the possibility of embryonic aneuploidy (An abnormal number of chromosomes, either excessive or deficient) before implantation. With the use of array comparative genomic hybridization (aCGH), we are able to achieve very high percentage of informed embryos (98%) using only one embryonic cell Preimplantation Genetic Screening (PGS) allows the specific selection of embryos which are chromosomally normal before implantation
PGT-A, or preimplantation genetic testing for aneuploidies, is a genetic test performed on embryos produced through IVF. PGT-A gives information about embryos’ genetic health to help your care team select the best embryo for transfer and improve your chance of achieving a successful pregnancy. PGT-A was formerly known as PGS, preimplantation genetic screening.
Preimplantation Genetic Testing for Monogenic/Single Gene Defects (PGT-M) for single gene disorders is the diagnosis of a genetic condition prior to achievement of a pregnancy. The examination of monogenic hereditary diseases (which appeared because of changes in a single gene). Preimplantation Genetic Diagnosis (PGD or PGT-M) is the unique method, offered by GG Hospital. If a woman or a man has a disease on the gene level, it is possible to define the precise localization of the problem and examine both the chromosome and the gene level to exclude such health problems for the unborn child.